Neither tesamorelin nor retatrutide has an established safety profile in pregnancy or breastfeeding
What the research shows: In the landmark STEP clinical trials, patients taking semaglutide lost an average of 15% of their body weight over 68 weeks
As metabolites are the substrates used to generate chromatin modifications, including methylation and acetylation modifications of histones, a complicated interaction exists between metabolism and epigenetics
When cells can move more efficiently, tissue repair accelerates
Cholesterol induction in CD8(+) T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites
With this representative, timely data, we look forward to partnering with more researchers to build representative and accurate real-world studies to power important real-world evidence and complement the insights found in clinical trials.